Cargando…

Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells

BACKGROUND: Glutaminase isoenzymes GLS and GLS2 play apparently opposing roles in cancer: GLS acts as an oncoprotein, while GLS2 (GAB isoform) has context specific tumour suppressive activity. Some microRNAs (miRNAs) have been implicated in progression of tumours, including gliomas. The aim was to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	de los Santos-Jiménez, Juan, Campos-Sandoval, José A., Márquez-Torres, Clara, Urbano-Polo, Nieves, Brøndegaard, David, Martín-Rufián, Mercedes, Lobo, Carolina, Peñalver, Ana, Gómez-García, María C., Martín-Campos, Janet, Cardona, Carolina, Castilla, Laura, da Costa Souza, Felipe, Cheng, Tzuling, Segura, Juan A., Alonso, Francisco J., Curi, Rui, Colquhoun, Alison, DeBerardinis, Ralph J., Márquez, Javier, Matés, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897386/ https://www.ncbi.nlm.nih.gov/pubmed/33610185 http://dx.doi.org/10.1186/s12929-021-00712-y

Ejemplares similares

Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines
por: De los Santos-Jiménez, Juan, et al.
Publicado: (2023)

Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism
por: Martín-Rufián, Mercedes, et al.
Publicado: (2012)

Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation
por: López de la Oliva, Amada R., et al.
Publicado: (2020)

Author Correction: Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation
por: López de la Oliva, Amada R., et al.
Publicado: (2021)

Glutaminase and MMP-9 Downregulation in Cortex and Hippocampus of LPA(1) Receptor Null Mice Correlate with Altered Dendritic Spine Plasticity
por: Peñalver, Ana, et al.
Publicado: (2017)

Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)

Metabolic changes in cancer cells upon suppression of MYC
por: Anso, Elena, et al.
Publicado: (2013)

Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
por: Márquez, Javier, et al.
Publicado: (2021)

Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
por: Ampuero, Javier, et al.
Publicado: (2012)

Reductive carboxylation supports growth in tumor cells with defective mitochondria
por: Mullen, Andrew R., et al.
Publicado: (2011)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

Análisis e interpretación de razones financieras para la toma de decisiones /
por: José Palemón Márquez Campos
Publicado: (2002)

The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016)

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)

Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Targeting glutaminase to starve lymphoma cells
por: Dumontet, Charles
Publicado: (2022)

Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway
por: Majewska, Ewelina, et al.
Publicado: (2019)

Metabolic heterogeneity in cancer
por: DeBerardinis, Ralph J
Publicado: (2014)

Q&A: Targeting metabolism to diagnose and treat cancer
por: DeBerardinis, Ralph J
Publicado: (2014)

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2015)

Metabolic modulation of neurogenesis: Role of glutaminase-2
por: Salomoni, Paolo
Publicado: (2014)

Targeting hepatic glutaminase activity to ameliorate hyperglycemia
por: Miller, Russell A., et al.
Publicado: (2018)

Safety assessment of glutaminase from Aspergillus niger
por: Vo, Trung Duc, et al.
Publicado: (2020)

Glutaminase inhibition in renal cell carcinoma therapy
por: Raczka, Aleksandra M., et al.
Publicado: (2019)

Identification and characterization of a novel glutaminase inhibitor
por: Cederkvist, Henning, et al.
Publicado: (2021)

Pyruvate dehydrogenase activity is required for optimal growth under lipid deficient conditions
por: Rajagopalan, Kartik, et al.
Publicado: (2014)

THDP17 Decreases Ammonia Production through Glutaminase Inhibition. A New Drug for Hepatic Encephalopathy Therapy
por: Díaz-Herrero, M. Mar, et al.
Publicado: (2014)

Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma
por: Ouyang, Zhen, et al.
Publicado: (2022)

Fundamentals of cancer metabolism
por: DeBerardinis, Ralph J., et al.
Publicado: (2016)

Structure and activation mechanism of the human liver-type glutaminase GLS2
por: Ferreira, Igor M., et al.
Publicado: (2021)

Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
por: Caiola, Elisa, et al.
Publicado: (2020)

Effect of glutaminase inhibition on cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2019)

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
por: Masisi, Brendah K., et al.
Publicado: (2021)

Differences in the use of spirometry between rural and urban primary care centers in Spain
por: Márquez-Martín, Eduardo, et al.
Publicado: (2015)

Kir4.2 mediates proximal potassium effects on glutaminase activity and kidney injury
por: Terker, Andrew S., et al.
Publicado: (2022)

From “N of 1” to N of more
por: DeBerardinis, Ralph J., et al.
Publicado: (2015)

Erratum: Majewska, E. et al. Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway. Cancers 2019, 11, 115
por: Majewska, Ewelina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6as7ht38htpv2e6qdka1s7vugb